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 ت يضرملا دىع ةدسكلاا ثاداضم و تيىهدلا ثاىيتوربلا , نوهدلا ةدسكا  ثارشؤم مييق
  عوىلا ىركسلاب هيباصملا2 قارعلا /فجىلا يف هيلوسولاا يلع هي دمتعملا ريغ 
         بٌلاخ ًف مهخ دوخوب ىَبثنا عوُنا يشكسنا ءاد فشؼٌ–  بتٍب– َ ا  يًٍن ًيف ٌبي فَ ىينا يدايٌ بيًي طبيٌشكُننا ًيف  شيثنك ٍٍنويس
يظُنا ًف مهخ ىنا يداٌ ازهك لونتنا ساشكتك شطؼنا ذيسنلان  دبيدًنا داويًهن وبيؼنا وب  ٍٍديسنك ا ذينوت شينتؼٌك يشكيسنا ءاد ىيىشي ًيف
 شسناROS    . يشكسنا ءاد ىىشي ًف منبشًنا ىها ٍي مهخنا ازهن  نزبيًنا  ٍُهذنا تبٍُتكشنناك ٌوهذنا  ذسنا حتاوَك  ٍي  فذهنا ٌإ
نا ِزييه ذييٌبهذن ا ً بييُ  ٌونبييًنا مييثي  ييٍُهذنا تبييٍُتكشنناك ٌوهذيينا  ذييسنا تاشييكاي ىٍييٍفت وييه  ييساسذMDA  ٌوهذيينا  ذييسنا ٍيي  حتبييُنا
 ًيهكنا لكشتيسنوكناكTC   يٍ لاثنا تاذٌشٍيسهكناكTG   يفبثكنا  يٍنبػ  يٍُهذنا تبيٍُتكشنناكHDL-C   يفبثكنا  يئطاككLDL-C    يئطاك ك
 اذيخ  يفبثكناVLDL-C   ا تادبيديك  ضٌذٍيسنكشٍب ٌوٌبي بتوهن ىٌضيَا ميثي  ذيسنGSH-Px   لضيتخًنا ٌوٌبي بتوهكنا كGSH, GR  
 ضٍنبتبكناك CAT  كٍنوننا ضيبز ضٍنشتك. UA   ىيهػ  يساسذنا ِزه تٌشخا ذقك06 يؼٌ بيدٌشيَبيثنا عويُنا يشكيسنا اشي  ٍي  ٌوَبى 
( ٍي ىهسبًػا ذكاشتت53 – 06ك  ُس )06 ت ىتك  طببى  ػوًدًن ءبسصا بيخك ك ِلايػا  سونزيًنا  ذيسن ا تادبيدي تبٌوتسي ىٍٍف
ًف ذٌبهذن ا ً بُ  ٌونبًنا كنزن ميي  بيهتَسبفيك وذينا مي ي ًيف شكسنا  دبٌضب بهطبنتساك  ٍُهذنا تبٍُتكشنناك ٌوهذنا ىهػ بهشٍ أتك وذنا
. طببدنا  ػوًدًنا غي  هذن ا ً بيُ  ٌونبيًنا ضيٍناشت ًيف  ٌوُؼي  دبٌص دوخوب  ساسذنا تشهظا تاذٌشٍيسٍهكناك ًيهكنا لكشتيسنوكناك ذيٌب
  يٍ لاثنااك  اذيخ  يفبثكنا  يئطاكك  يفبثكنا  يئطاك  يٍُهذنا تبيٍُتكشنن بهساذيفي P< 0.001  دويخك عزوين بيًٍُب  طببيدنا  يػوًدًنبب  يَسبفي
  يفبثكنا  يٍنبػ  ٍُهذنا تبٍُتكشننا تبٌوتسي ًف ٌبيفَ . P< 0.001 عزوين ذيقك د كر ظويسهي يويُؼي ابياخَا دويخك ًيف  ٍ بي زا  ين 
 ذيسن ا تادبيدي تبٌوتسي   GSH-Px  ,GSH  ,GR   P< 0.001    ضٍهتبيكنا كوتيسي ًيف  طٍيسب  دبيٌصكCAT  كيٍنوننا ضيبيزك
UA  P< 0.001       شطٍسنا  ػوًدًب   َسبفي . ك ً بيُ  ٌونبيًنا  دبيٌصك  ذيسن ا تادبيدي كوتيسي ابياسَا  يساسذنا ِزه ٍي حتُتسَ
ن  شكاًن ذٌبهذن ا  يٍاٍن ذيٌذست يسكشيدنا ٍي  رنيصاك ,وذينا مي ي ًيف شكسنا  دبٌص ىنا يداٌ يذسنأت دبهخا ىنا شٍشٌك ٌوهذنا  ذس
 مثي جلاؼن  ذسن ا تادبدي واذختساك مهخنا ازه ٍػ لكاسًناك يذسنأتنا دبهخ ا ثكذز.VIT- E, VIT-C  
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Abstract: 
Background:  
        Diabetes mellitus arises when insufficient insulin is produced, or when the available insulin does 
not function correctly. Without insulin, the amount of glucose in the blood stream is abnormally high, 
causing unquenchable thirst and frequent urination. The body’s inability to store or use glucose causes 
hunger and weight loss 
(1)
 . Type 2  diabetes – occurs when there is a severe lack of insulin due to the 
destruction of most or all of the beta (ß – cells) in the islets of Langerhans. Diabetes mellitus is 
considered to be one of a rank of free radical diseases which propagates complications with increased 
free radical formation. Oxidative stress is increased in diabetes mellitus owing to the increase in the 
production of oxygen free radicals and a deficiency in antioxidant defense mechanisms. Lipid 
peroxidation of cellular structures, a consequence of increased oxygen free radicals, is thought to play 
an important role in atherosclerosis and microvascular complications of diabetes mellitus . 
Hyperlipidaemia has also been reported as one of the causative factors for increased lipid peroxidation 
in diabetes mellitus. The study was designed to find out the relationship between lipid peroxidation,  
and complication of diabetes mellitus and to   estimate the mutual relationship between serum 
lipoproteins levels and diabetes severity 
(2).   
   Introduction  
          Diabetes Mellitus Is caused by on absolute or relative insulin deficiency . It has been defined by 
the World Health Organization (WHO) , on the basis of laboratory findings, as a fasting venous plasma 
glucose concentration more than or equal to 7.0 mmol/L (on more than one occasion or once in the 
presence of diabetes symptom ) or random venous plasma glucose concentration more than or equal to 
11.1mmol/L 
(3)
 . Non-insulin-dependent  type 2 diabetes – occurs when the body does not produce 
enough insulin, and the insulin that is produced becomes less effective. This type of diabetes usually 
appears in people over the age of 40, and tends to have a more gradual onset. In most cases, glucose 
levels in the blood can be controlled by diet, or diet and tablets, although sometimes insulin injections 
may be needed. About 90 per cent of diabetics are non-insulin dependent 
(4)
. There are probably 100 
 2 
million people in the world with diabetes mellitus and incidences of diabetes are on the rise. As 
diabetes progress patients are at increased risk of developing coronary disease 
(4)
. Insulin deficiency 
causes excessive metabolisation of free fatty acids, this may lead to a disorder in lipid metabolism. 
Insulin is a hypoglycemic hormone secreted from β-cell of the islet of pancreas. Insulin also has an 
effect on lipid metabolism 
(5)
 .  
       Type 2 diabetes (non-insulin-dependent diabetes) is a multi-causal disease which develops slowly 
and in a stepwise order 
(6-8)
. Initially it commences with insulin resistance, which progress gradually 
with time until the body fails to maintain glucose homeostasis resulting in glucose intolerance. 
Systemically these perturbations are accompanied with changes in a variety of biochemical processes 
such as obesity, an altered lipid profile and lipid peroxidation 
(9)
. 
       Oxidative damage to unsaturated lipids is a well-established general mechanism for oxidative 
stress-mediated cellular injury 
(10)
 , in addition to increased lipid peroxidation 
(11)
. The occurrence of 
free-radical-induced lipid peroxidation causes considerable changes in the cell membrane 
(12)
 . 
Peroxidation of the lipid membrane has been related to the pathogenesis of many degenerative diseases, 
such as atherosclerosis, aging, carcinogenesis and diabetes mellitus 
(13)
. Evidence suggests that 
oxidative stress is increased in diabetes, because of excessive production of reactive oxygen species 
(ROS) and an impaired antioxidant defence mechanism
(14,15)  
 . It has been suggested that ROS induce 
membrane lipid peroxidation and that the toxicity of the generated fatty acids peroxides are important 
causes of cell malfunction 
(16)
.  The most widely used assay for lipid peroxidation involves the 
measurement of malondialdehyde (MDA) due to its simplicity. Thus, the lipid peroxide in the blood 
provides useful information for the prognosis of diabetes in which secondary disorders are often fatal 
(17)
. Antioxidants can be defined as substances whose presence in relatively high concentration 
significantly inhibits the rate of oxidation of lipids, proteins, carbohydrates and DNA. Antioxidants 
such as uric acid (UA and glutathione (GSH) act as potent electron donors; they donate hydrogen 
atoms to pair up with unpaired electrons on free radicals. Thus, they convert reactive free radicals into 
inactive substances 
(18)
. The determination of the oxidative stress and antioxidants require sometimes 
invasive techniques such as taking blood samples. 
     The aim of the present study was to determine the levels of serum glucose ,lipid peroxidation 
marker (MDA), lipid profile; total cholesterol (TC), high density lipoprotein (HDL), Triglyceride(TG), 
Low density Lipoprotein(LDL) and very Low Lipoprotein(VLDL) and make a statistical study on these 
parameters were done by the methods based on enzymatic determination  and antioxidant parameters 
Glutathione peroxidase(GPx), Reduced Glutathione(GSH), Glutathione redactase(GR), Catalase(CAT) 
and Uric acid(UA) in patient with Diabetes mellitus.  
Material and Method 
Chemical and Apparatus 
         All laboratory chemical and reagents were of analar grade . Trichleroacetic acid ,was obtained 
from Hopking Williams, Thiobarbituric acid from Merek Germany Co. ltd, reduced glutathione from 
Biochemical
'
s Co. Ltd, Hydrogen peroxide from Merek CO. Ltd, (di-potassium hydrogen phosphate, 
potassium dihydrogen phosphate and di-sodium hydrogen phosphate from Merek Germany Co. ltd) 
were used during our study , lipid profile and uric acid from BIOLABO SA laboratories Ltd. France  
Patients and control subjects 
      Sera of 100  subject were collected, ,  out of which 40 apparently healthy individuals of age group 
(35-70 years) were taken as control with normal plasma glucose include (20) male and (20) female . 
(60) elderly with non insulin dependent (NIDDM) subjects of age  (35-70 years) were taken as cases 
include (30 ) males and (30 ) females were obtained from Al-Najaf Center for diabetes and Endocrine 
Department in Al - Sader Medical Teaching City / Najaf/ Iraq and the results were compared with  
healthy individuals with comparable age . The (NIDDM) Patients were not taking any medicines other 
than oral anti- diabetic pills for the past four years . Patients suffered from other disease interferes with 
data excluded in the current study . The study was carried out at the Department of Biochemistry . 
College of Medicine , University of Kufa.  
Blood specimens  
       Disposable syringes and needles were used for blood collection . Blood samples were obtained 
from patients and control group by vein puncture. Sample were allowed to clot at 37 
0
C  then 
centrifuged at 3000 Xg for 10 minutes. Sera were removed and stored at -20 
0
C until analysis time.  
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Fig (2):Correlation between Total cholestrol (TC) and high density 
lipoprotein (HDL)
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Fig (3) :Correlation between Triglyceride (TG) and high density 
lipoprotein (HDL)
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Methods  
        Both cases and controls were subjected to estimation  of biochemical parameters like Fasting 
plasma Glucose (FPG)  
(19)
, Total cholesterol (TC), Triglyceride (Tg), HDL-Cholesterol, LDL-
Cholesterol and VLDL-Cholesterol
(20,21) 
.GSH-Px was assayed according to the procedure of Rotruck 
etal  with some modification
(22)
 while reduced  Glutathione was assayed as described by Burits etal  
(23)
. 
(by spectrophtometric assay based on 5,5- dithiobis - nitrobenzoic acid ) on the other hand Glutathion 
redactase (GR) was assayed by enzymatic method by Horn 
( 24)
 Catalase CAT activity was  assayed as 
described by Aebi H
(25)
 and uric acid also was assayed by enzymatic method
(26)
 .Malondialdehyde was 
assayed using thiobarbituric reactive substances method described by Guidet B and Shah 
(27) 
.   
     Type 2 diabetes mellitus patients were diagnosed on the basis of history, physical examination and 
biochemical investigations and according to the biochemical criteria laid down by the National 
Diabetes Data Group (NDDG) of the National Institute of health in 1985/WHO criteria 
(28)
 .The 
diagnosis of NIDDM was based on the criteria of the Expert Committee on the Diagnosis and 
Classification of Diabetes  mellitus (2000) 
(29)
 . 
 Biostatistics analysis  
       The result were expressed as mean ± SD. Students t-test was used for comparison of results of 
patients and the control group. Significant variation was considered when p value was less than < 0.05. 
The correlate between the values of oxidative stress parameters and various factor  were performed by 
the liner regression analysis Table( 3) and Figures (1- 5). 
Results 
     In the current study we observed a   significant increase p < 0.001 in the lipid profile was observed 
except HDL cholesterol, which was decreased Table(1) and Figures(1,2) , Also significant decrease p < 
0.001 in antioxidant enzymes such as glutathione peroxidas , reduced glutathione, glutathione 
reductase, except uric acid and catalase were seen as compared to the control subjects Table(2). Other 
findings observed was that the level of lipid peroxide (MDA) increased as per the increase in 
concentration of blood glucose. Our findings indicate that the increase in the lipid peroxidation product 
MDA together with uric acid and catalase and decline in glutathione-dependent antioxidant defenses 
may appear early in non insulin dependent type 2 diabetes mellitus patients  (NIDDM). Serum MDA 
had a week positive relation with serum UA and serum CAT.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig (4) :Correlation between triglycerid (TG) and very low density lipoprotein (VLDL)
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Table (1) .Serum value of lipid profile in type 2 diabetes mellitus and the control group  
 
Parameters    Control       Patients   
  Mean ± SD 
N = 40 
       Range  Mean ± SD 
     N = 60 
     Range    P- value 
TC(mmol/L) 
 
TG(mmol/L) 
 
HDL-(mmol/L) 
 
LDL-C(mmol/L)  
 
VLDL–C(mmol/L)  
 3.91± 0.66 
 
 1.68± 0.3 
 
 1.89± 0.36 
 
 2.42± 0.36 
 
   0.36± 0.1    
   1.6 – 9.4 
 
 0.53–4.72 
 
0.32– 2.29 
 
    1.3 - 5.5 
 
0.47– 1.79 
  6.138 ± 1.2 
 
 2.05 ±  0.51 
 
 1.2 8 ± 0.26 
 
   3.84± 1.15 
 
   0.93± 0.26    
  2.45– 14.9 
 
  0.98- 5.9 
 
   0.78 – 2.2 
 
   1.34 – 8.6 
 
   0.34 – 2.7 
  < 0.001 
 
  < 0.001 
 
  < 0.001 
 
  < 0.001 
 
  < 0.001 
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density 
lipoprotein cholesterol; VLDL-C, very low-density lipoprotein . 
 
 
 
Table (2). Serum value of the status of antioxidant enzymes and Malodialdehyde (MAD) in type 2 diabetes 
mellitus and control group .     
Parameters  Control    Patients   
    Mean ± SD 
N = 40 
   Range  Mean ± SD 
N = 60 
         Range    P- value 
GSH (µmol/L) 
 
GPx (U/ml) 
 
GR-(U/ml) 
 
CAT (K/ml)  
 
U.A–(mmol/L)  
 
MDA (µmol/L) 
   284 ± 58 
 
   3.92 ± 1.16 
 
   1.68 ± 0.33 
 
   60  ± 6.6 
 
 0.29 ± 0.039 
 
5.64 ± 0.58   
  113 – 553 
 
 1.4–8.8 
 
 0.65 –4.02  
 
26.7 -133.2  
 
0.126 –0..66 
 
2.53 – 12.4 
  139 ± 34 
 
 2.48 ±  0.74 
 
 1.3 8 ± 0.27 
 
  65.6 ± 19 
 
  0.35 ± 0.08 
 
  10.66 ±  3.2    
52 – 287 
 
0.47 - 6.13 
 
0.5 – 3.2 
 
23.3 -169.2 
 
0.135 –0..86 
 
 3.24 - 20.5 
    < 0.001 
 
    < 0.001 
 
    < 0.001 
 
    < 0.001 
 
    < 0.001 
 
    < 0.001 
GSH, Glutathione; GPx, Glutathione peroxidase; GR, Glutathione reductase ; CAT , Catalase ; UA, Uric acid ; 
MDA, Malondialdehyde. 
 
 
 
 
 
 
Fig (5) :Correlation between High density lipoprotein (HDL) and 
Low density lipoprotein (LDL)
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 Table ( 3). Correlation among serum estimation of lipid profile in patients with  diabetes mellitus  
 
Parameters           R       P – value 
TC with TG    0.768    < 0.001 
TC with HDL- C  - 0.6   < 0.001 
TC with LDL- C    0.71   < 0.001 
TC with VLDL-C    0.548   < 0.01 
TG with HDL- C -  0.55   < 0.01 
TG with VLDL-C    0.932   < 0.001 
HDL with LDL-C  - 0.565   < 0.01 
HDL with VLDL-C  - 0.422   < 0.05 
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein TC, total cholesterol; 
TG, triglycerides cholesterol; VLDL-C, very low-density lipoprotein .  
 
Discussion 
       In diabetes mellitus, abnormally increased levels of lipids, lipoproteins and lipid peroxides in 
plasma may be due to the abnormal lipid metabolism
(13)
. Patients with type 2 diabetes frequently have 
an abnormal blood lipid profile consisting of moderately elevated LDL-C, moderately decreased HDL-
C, and high TC and triglycerides (Table 1). Thus, inadequate levels of HDL-C, in conjunction with 
more atherogenic forms of LDL-C may contribute to atherogenesis 
(30)
 . The results of the present study 
showed approximately a two-fold increase in serum levels of all lipid fractions (except for HDL-C) for 
diabetic group when compared with control group Table (1). 
      Hypertriglyceridemia and hypercholesterolemia were associated with oxidative modification of 
LDL-C, protein glycation and glucose auto oxidation, thus leading to excess production of lipid 
peroxidation products which may cause elevation of oxidative stress in higher lipid and hyperlipidemic 
subjects 
(31)
 Table (2). Enhanced oxidative stress was indicated by increased free radicals production 
(32)
 
.lipid peroxidation and reduced antioxidant status 
(33)
. Several studies have reported an increased 
susceptibility to lipid peroxidation in patients with diabetes mellitus 
(34)
 . The generation of free radicals 
may lead to lipid peroxidation and the formation of several types of damage in diabetes mellitus.  In the 
present study, we have observed that MDA levels, a lipid peroxidation product and a marker of 
oxidative stress, were elevated significantly in diabetic patients 
(35)
 . 
       Uric acid  UA is the end product of purine metabolism; it can act as a pro-oxidant, particularly at 
increased concentration Table (2) and may thus be a marker of oxidative stress 
(36-37)
 . but it may also 
have a therapeutic role as an antioxidant 
(38,39)
 . Thus, it is unclear whether the increased concentration 
of UA in diseases associated with oxidative stress, such as diabetes mellitus, are a protective response 
or a primary cause. It is worth noting that hyperuricemia has been found to be associated with obesity 
and insulin resistance and consequently with type 2 diabetes mellitus 
(40-42)
 .Chen et al, (2008) 
(43)
 . 
      Sailaja et al (2003) 
(44)
. reported that diabetic humans have shown increased lipid peroxidation and 
decreased levels of glutathione peroxidase, reduced GSH and glutathione reductase  Table (2). These 
data suggest that the oxidative stress in these pathologies does not depend on a loss of GSH or a lack of 
GSH synthesis alone, but a misbalance in the oxidant/reduction cycle of GSH
(45)
 . 
     Reznick et al (2006) 
(46)
. have shown that oxidative stress exists in diabetic patients as evidenced by 
the increased total antioxidant capacity in the blood of patients. Indeed, there is evidence that suggests 
that endogenous antioxidant capacity is eroded in diabetes, due to several factors, including the impact 
of non-enzymatic glycation on key enzymes, the polyol pathway and its consumption of reducing 
power, as well as the constant demands of oxidative stress 
(47-52)
 . The present study showed that 
elevated serum endogenous antioxidant activity among diabetics is a response to the damaging effect of 
free radicals release due to increased oxidative stress. Indeed, the detection of increases in UA levels 
should therefore alert clinicians to the commensurately increased vulnerability of the diabetic patient to 
life-threatening cardiovascular complications.   
     GSH is a ubiquitous tri- peptide that presents in red cells and participates in GPx reaction. When 
H2O2 is detoxified by GPx, the GSH is simultaneously converted to the oxidized form (GSSG). In the 
present study,  found that GSH levels in type 2 DM patients were significantly lower than that in their 
same age-matched control subjects. These results are in good agreement with other studies 
(53-55)
. As 
already mentioned GSH serves as an essential cofactor for the enzyme GPx and formed oxidized 
glutathione (GSSG) during the enzyme processes . Thus, increasing in GPx activities imply higher 
consumption of GSH. Other mechanisms that may explain the GSH reduction in diabetes are that the 
 6 
GSH is regenerated by the enzyme glutathione reductase, using reducing equivalents from NADPH. 
The NADPH is generated in red blood cells through the pentose phosphate pathway, which is 
stimulated by insulin 
(56)
. NADPH production in DM may be sluggish, probably resulting in lowered 
glutathione reductase activity and reduced GSH recycle. 
      The enzyme glutathione reductase was found to be decreased in type 2 diabetic patients as reported 
by Dincer etal (2002)  
(57)
. Moreover in diabetes mellitus, the increased sorbitol synthesis via the polyol 
pathway occurred. This elevated sorbitol production caused the NADPH depletion that was required by 
aldose reductase enzyme in this pathway. This deficiency will also limit the GSH recycle 
(57)
. There is 
still a controversial view regarding alteration in the activity of catalases in diabetic subjects. According 
to some scientist increase in level of catalase is compensatory for the removal of free radical, in the 
absence of glutathione peroxidase in type II diabetes mellitus 
(58)
. We found in our study increased 
catalases level which is in agreement of other reports.   
     In conclusion, the assay of  oxidative stress parameter has brought substantial insight into the patho-
genesis and evolution of diabetes. Thus, subjects at high risk of developing hyperlipidemia may benefit 
from treatment with antioxidants such as vitamin E and C, which might assist endogenous antioxidant 
capacity and reduce peroxidation rates. Whether such supplementation might possibly delay or even 
prevent complications of this disease is an area of ongoing investigation. 
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